This article highlights the data currently available on the activity of targeted medical treatment in a subgroup of rare entities within soft tissue sarcomas, including inflammatory myofibroblastic tumor, alveolar soft part sarcoma, solitary fibrous tumor, malignant perivascular epithelioid cell tumor (PEComa), and clear cell sarcoma.

Targeted Therapies in Rare Sarcomas : IMT, ASPS, SFT, PEComa, and CCS / S. Stacchiotti, A. Marrari, A.P. Dei Tos, P.G. Casali. - In: HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. - ISSN 0889-8588. - 27:5(2013), pp. 1049-1061.

Targeted Therapies in Rare Sarcomas : IMT, ASPS, SFT, PEComa, and CCS

P.G. Casali
Ultimo
2013

Abstract

This article highlights the data currently available on the activity of targeted medical treatment in a subgroup of rare entities within soft tissue sarcomas, including inflammatory myofibroblastic tumor, alveolar soft part sarcoma, solitary fibrous tumor, malignant perivascular epithelioid cell tumor (PEComa), and clear cell sarcoma.
Alveolar soft part sarcoma; Chemotherapy; Clear cell sarcoma; Hemangiopericytoma; Inflammatory myofibroblastic tumor; Perivascular epithelioid cell tumor; Sarcoma; Solitary fibrous tumor; Oncology; Hematology
Settore MED/06 - Oncologia Medica
2013
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/485141
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 17
  • OpenAlex ND
social impact